BioLargo, Inc.
BLGO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -60.3% | -15.1% | -10.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.7% | 51.2% | 45.5% | 47.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -572.7% | -62% | -55% | -42.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -587.4% | -42.9% | -35.3% | -27.7% |
| EPS Diluted | -0.02 | -0.004 | -0.004 | -0.003 |
| % Growth | -412.8% | -2.6% | -11.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |